Among older adults and adults with low atherosclerotic cardiovascular disease risk, use of aspirin decreased after 2019.
Many historically underrepresented groups, individuals on Medicaid and some without insurance at low atherosclerotic risk continue to take low-dose aspirin despite bleeding risk, in contrast to recent ...
That was followed by a 2022 recommendation from the U.S. Preventive Services Task Force (USPSTF) stressing that people ages ...
After guideline changes, aspirin use dropped off overall, even for higher-risk patients in whom it might still be considered.
That was followed by a 2022 recommendation from the U.S. Preventive Services Task Force (USPSTF) stressing that people ages ...